Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-18-055391

Director acquired 6,535 shares (other)

From the SEC's structured data for this filing

Trades in this filing

MESSEMER DEBORAH M. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-15 Other acquisition : show line 1 in the form +6,535 6,535 I
Loading xslF345X03/doc4.xml…